Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
AXON$422.00+7.40(+1.78%)Axon Announces Body 5: Next-Generation Camera Built for the AI Era Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more...[1:00:00 PM ET]PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]

RDW · NYSE

Redwire Corporation

$8.34 +0.22 (+2.76%)

Company overview

Redwire Corporation, a space infrastructure company, develops, manufactures, and sells mission-critical space solutions and components for national security, civil, and commercial space markets in the United States, Luxembourg, Germany, South Korea, Poland, and internationally. The company provides various antennas, advanced sensors, and components, including solar arrays, composite booms, radio frequency antennas, payload adapters, space-qualified camera systems, and star trackers and sun sensors. It also offers a proprietary enterprise software suite that enables digital engineering and the generation of interactive modeling and simulations of individual components, entire spacecraft, and full constellations through a cloud-based Software as a Service business model.

Sector
Industrials
Industry
Aerospace & Defense
Exchange
NYSE
Market cap
$2.1B
Employees
750
Headquarters
Jacksonville, FL
CEO
Peter Anthony Cannito Jr.
Listed
January 14, 2021
P/E
-3.11
Dividend yield
0.00%

Company financials

Revenue
$371M
Gross profit
$34.1M
Operating income
-$284M
EBITDA
-$210M
Net income
-$300M
EPS
-$2.68
Total assets
$1.5B
Total debt
$209M
Gross margin
9.18%
Net margin
-80.90%
Earnings yield
-32.13%

Revenue segmentation

By product (FY 2025)

No product segmentation.

By region (FY 2025)

Showing FY 2025

Price chart

7.0012.1017.2022.3027.40
RDW 1D NYSE O8.00H8.44L7.84C8.36+0.22 (+2.70%)Vol10.07M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
RDW Stock news Could Redwire Be the Next Rocket Lab? The Motley Fool
RDW Stock news SpaceX Rallied, but These 6 Space Stocks Are Still Waiting for Liftoff 24/7 Wall Street
RDW Stock news Forget the Anthropic IPO. Here Are 6 Stocks Worth Watching. The Motley Fool
RDW Press release Chips Bounced, Builders Sank and Crude Sent Mixed Signals Heading Into Tuesday Technology stocks led a partial recovery on Monday after last week's AI-driven selloff. The Nasdaq Composite rose about 1.1%, the S&P 500 gained... PR Newswire
RDW Stock news This Eloxx Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday Benzinga
RDW Stock news Redwire Secures Additional Orders to Deliver Stalker UAS to U.S. National Guard for the Army's Next-Generation Drone Operators Business Wire
RDW Stock news Can Redwire's VLEO Spacecraft Expand Mission Opportunities? Zacks Investment Research
RDW Press release Air Launch Is Back on the Space Industry's Flight Plan American News Group News Commentary - The global space launch services market was valued at $16.9 billion in 2022 and is projected to reach $29.6... PR Newswire
RDW Press release Final Pair of Redwire ROSA Wings Launch to the ISS, Completing Historic Power Modernization Effort Business Wire
RDW Stock news SpaceX Is Public. Here's What $1,000 in Each of These 5 Space Stocks Could Be Worth by 2030. The Motley Fool
RDW Stock news Redwire vs. Rocket Lab: Which Industrials Stock Is a Better Buy in 2026? The Motley Fool
RDW Stock news Redwire's Defense Business Is Getting Bigger. Can Profits Follow? The Motley Fool
RDW Stock news Intuitive Machines Falls 7% Despite Scaling Up Satellite Manufacturing; Rocket Lab and Redwire Drop 5% 24/7 Wall Street
RDW Stock news Can Redwire's Microgravity Pharma Work Create New Revenue Streams? Zacks Investment Research
RDW Stock news Redwire Falls 5% as Space Stocks Sell Off Together; Rocket Lab Drops 4%, Intuitive Machines Slides 6% 24/7 Wall Street
RDW Stock news Intuitive Machines vs. Redwire: Which Space Race Stock Is a Better Buy in 2026? The Motley Fool
RDW Stock news This Hot Space Stock Just Lands Major Axiom Contract GuruFocus
RDW Stock news Redwire Awarded Follow-On Contract to Provide Roll-Out Solar Array Wings for Axiom Space's Second Space Station Module GuruFocus
RDW Press release Redwire Awarded Follow-On Contract to Provide Roll-Out Solar Array Wings for Axiom Space's Second Space Station Module Business Wire
RDW Stock news SpaceX Just Upped The Ante On Rocket Lab 24/7 Wall Street
FAQ

Questions about Redwire Corporation

What does Redwire Corporation do?
Redwire Corporation, a space infrastructure company, develops, manufactures, and sells mission-critical space solutions and components for national security, civil, and commercial space markets in the United States, Luxembourg, Germany, South Korea, Poland, and internationally. The company provides various antennas, advanced sensors, and components, including solar arrays, composite booms, radio frequency antennas, payload adapters, space-qualified camera systems, and star trackers and sun sensors. It also offers a proprietary enterprise software suite that enables digital engineering and the generation of interactive modeling and simulations of individual components, entire spacecraft, and full constellations through a cloud-based Software as a Service business model.
What is RDW's market cap?
Redwire Corporation (RDW) is a listed stock with a live quote. The latest market cap on this page is $2.1B.
Where is Redwire Corporation headquartered?
Redwire Corporation is headquartered in Jacksonville, FL.
How do I get RDW news from the API?
Call GET /v1/news?tickers=RDW. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does RDW news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for RDW, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the RDW price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.